
æ£è ã®AIãšæŠããªãâäžè 蚺çã®æä»£
# AIã䜿ã£ãŠãèšããªãæ£è
# é²è¡ç察å¿ãšåå å察å¿
# è§£éã¢ãã«ã«AIãšããå
±èè
# äžè
ã®ã±ã¢ïŒtriadic careïŒ
# AIãšæŠãããäŒè©±ã«åå ããã
ãã§ããAIã¯é¢ç¯ãªãŠããããããšèšã£ãŠããŸãã
倿¥ã§ãããåŒãäžãããªãæ£è ã«åºäŒã£ãã
ãããããé¢ç¯çãªããã
ããŠãããªãšãã¯ã©ããããã€ã©ããšããŠAIããšåŠå®ããããäžæãåã蟌ãããåã蟌ããªãã©ãåã蟌ãã§ããã®ãè¯ããŠã泚æãã¹ãããšã¯äœãã
ããŒã©ã³ãã§Instagramãªã©ã®SNSã䜿ã£ãŠããæäºº1,044人ã«è¡ããã調æ»ãããïŒWójcik S, et al. Front Digit Health. 2026;8:1933451ïŒãçŽåæ°ããå蚺åã«AIã䜿ã£ãŠããã®ã ããé©ããã®ã¯ãã®å ã§ãAIã䜿ã£ã人ã®82.5%ãããã®ããšãå»åž«ã«äŒããŠããªãã£ãã
AIã䜿ã£ãŠããŠãå»åž«ã«ãããäŒããŠããªãã
äŒããªãçç±ã§å€ãã£ãã®ããå»åž«ã«åŠå®çãªåå¿ããããã®ãå¿é ãïŒ86.4%ïŒã次ããå»åž«ã®æš©åšãæããããªããïŒ74.9%ïŒãç¥ãã¬ã¯å»åž«ã°ããã
äžåœã§AIå©çšè 48人ã«ã€ã³ã¿ãã¥ãŒããç ç©¶ã§ããåã話ãåºãŠããïŒDing W, Wang J. J Med Internet Res. 2026;28:e95072ïŒãå€ãã®äººãAIã䜿ã£ãããšãå»åž«ã«é ããŠããã
ãªãã»ã©ãã§ãAIã¯ããèšã£ãŠããŸãããšå£ã«ããæ£è ã¯å°æ°ãªã®ãã
ãã¡ããæ£è ãAIã䜿ã£ãããšã«ããããŸãããã±ãŒã¹ãããã
俺ã®å€æ¥ã«ã¯ããåå äžæããšæžããã玹ä»ç¶ãæã£ãè¥ãæ£è ãããããæ¥ããèæã ããããããè¥ã人ã®8ã9å²ä»¥äžã¯ããAIã䜿ã£ãŠããããããŠã蚺å¯ããŠããèŠåœãã€ããããã®ç æ ãç æ°ãªããæ£è ãããããªãè¿ããšãããŸã§èªåã§ãã©ãçããŠããã
蚺æããããšãããã£ã±ããã£ãŠèšãããããŠä¿ºãå¿ã®ãªãã§ãããã£ã±ãããšæãã
ãã®åŸã®èšºçã¯ãšãŠãã¹ã ãŒãºã ãã ã£ãŠæ£è ããã§ã«èª¿ã¹ãŠãã®ããšãããçšåºŠç¥ã£ãŠããã®ã ããã
å ã®äžåœã®ç ç©¶ã§ã¯ã546人ã®è³ªåçŽèª¿æ»ãããŠããã®ã ããAIã®èª¬æã§å»åž«ã®èšºæã確ããããããå»åž«ã®èããçè§£ã§ããããšæããŠãã人ã»ã©ãå»åž«ãžã®ä¿¡é Œãé«ãã£ããèè ãã¡ã¯ãAIã¯å»åž«ã®æš©åšãæžããããšããããããå蚺ã®ååŸãã€ãªããæ å ±ã®ä»²ä»åœ¹ãã«ãªã£ãŠããã®ãããããªãããšãŸãšããŠããã
ãã¡ãããã¡ãããšããç¥èãããå»åž«ããšããåæãããã®ã ãã
å°ãã®ã¯ãAIãšå»åž«ã®èŠç«ãŠããºã¬ãæã
ãã®ãããã®è«æãæ¢ã£ãŠã¿ãã
ã²ãšã€ç®ã¯ããŸã£ããåãå»ççã¢ããã€ã¹ã«ãå»åž«ããAIããå»åž«ïŒAIãã®ã©ãã«ã ããä»ãæ¿ããŠèŠããå®éšãAIãšæžãããŠããã ãã§ãä¿¡é Œæ§ãå
±æã®è©äŸ¡ãäžãããåŸãããšããæ°æã¡ãäžãã£ãïŒè±åœãªã©ã®2,280人ãReis M, et al. Nat Med. 2024;30:3098-3100ïŒãAIãäœã£ãã¹ã©ã€ãããšåãããšèª¬åŸåã»ä¿¡é ŒåºŠãèœã¡ãããšããã®ã¯ãã§ã«ããžãã¹ã§ã¯å®èª¬ã«ãªã£ãŠããã®ã ãããããšäŒŒãŠããã
ããã²ãšã€ã¯ãå»åž«ã®åçãšAIã®åçããåºæãäŒããŠèªãŸããå®éšã人ã¯ã»ãšãã©èŠåãããããå»åž«ããäžæ£ç¢ºããšå€å®ããAIã®åçã§ãããå»åž«ã®åçãšåããããä¿¡é ŒãããïŒçŽ300人ã䜿ãããã®ã¯å€ãGPT-3ãShekar S, et al. NEJM AI. 2025ïŒã
ããªãã»ã©ãAIããšããã©ãã«ãèŠãããšã人ã¯ãããªãã«è·é¢ã眮ãããå€ãããšãããåãããªãããããããã ãããAIã£ãœããªãã¹ã©ã€ãã«ããŠãAIã£ãœããªãæç« ã«æ·»åããŠããšAIã«é Œãã®ã¯ä¿ºã ã£ãŠæ¯æ¥ãã£ãŠããã
蚺å¯å®€ã®æ£è
ã®AIæ
å ±ã«ããããŠã©ã察å¿ããã°è¯ãã®ãïŒ
ãããã§èª¿ã¹ãŠããæ£è
ãããžã®å»åž«ã®å¯Ÿå¿ãæŽçããã·ã¹ãããã£ãã¯ã¬ãã¥ãŒãããïŒLu Q, Schulz PJ. J Med Internet Res. 2024;26:e47620ïŒã
å¯Ÿå¿æ¹æ³ã¯ã倧ããåãããšäºã€ã§ãdefensive approachïŒé²è¡çãªå¯Ÿå¿ïŒãš participative approachïŒåå åã®å¯Ÿå¿ïŒãåè
ã¯ããããã®æ
å ±ã¯åœãŠã«ãªããŸããããšæ
å ±æºããšåãæšãŠããåŸè
ã¯ãäœãèŠãŠããã®ããèããŠãäžç·ã«åå³ããã
ããã¯å¥ã«æ°ããããšã§ã¯ãªããåå»ã®èšã£ãããšããããµãªåãæšãŠãããåå»ã«å¯ŸããŠããçšåºŠè¯å®çã«å¯Ÿå¿ããã®ããã©ã¡ãããããããã¡ããåŸè ãè¯å»ã
人ã¯ãåŠå®çãªããšããã人ã奜ãŸãªãã
participative approachãAIæ
å ±å«ããŠäœãèããŠãããæ£è
ã®èããèããŠãäžç·ã«åå³ããã
ã€ãŸããå»åŠçã®æã«èãïŒãšèšãããã§ããããè§£éã¢ãã«ãã§ããããã ãè§£éã¢ãã«ã«åŒ·åãªå
±èè
ã€ããŠããã
å®èšåºã§ã¯æ®éã«ãè§£éã¢ãã«ãèãã°ãããæ®éã«ãçã®å蚺çç±ãèããŠãè§£éã¢ãã«ãèããäœã«å°ã£ãŠãããã»äœãã§ããªããªã£ããèããå¿ãããªãå蚺祚ã«å ¥ããŠããã°ããããã¡ã¯å ¥ããŠããã
以åããã蚺çãäžã€ã®åã§èããŠãããå»åŠçãªãšããã³ã¹ãæ£è
ã®ãã©ãã£ããå»åž«ã®ãã©ãã£ããäžã€ãéãªããšããã§ã蚺æãæ¹éãæ±ºããã

æåã¯AIå ¥ããŠ4ã€ã®åããªãšæã£ããããããããAIã¯æ£è ã®ãã©ãã£ãã«ãå»åž«ã®ãã©ãã£ãã«ããããããããã¯AIãEvidenceäœæã«ãçµã¿èŸŒãŸããŠããã§ãããããããããããã«AIããããããžã¿ã«ãã€ãã£ãŒã®ããšãã
BMJã®reviewïŒFraile Navarro D, et al. BMJ. 2025;391:e085325ïŒã¯ããã®ç¶æ³ãæ£è
ã»å»åž«ã»AIã®ãäžè
ã®ã±ã¢ïŒtriadic careïŒããšåŒã³ã蚺å¯ã¯äºå®ãåãæž¡ãå Žããã説æãäžç·ã«ã€ããå ŽïŒco-producing explanationsïŒã«å€ãã£ãŠããã ããããšæžããŠããããªãã»ã©ãè¶
ãšãªãŒãã®æ¯èŠªãåã«ïŒäžè
é¢è«ã«èšãå¹³å¡ãªæ
ä»»ããããªã€ã¡ãŒãžã ã

é¢ç¯çã®æ£è ããã®è©±ã«æ»ããããã®æ¥ãæ£è ã®AIãšæŠãæå³ã¯ãªããšæãã代ããã«ãããã®AIã®ç»é¢ãäžç·ã«èŠãŠãããã§ããããšãé¡ããããåæãããã£ãŠãæ£è ããã®ã¹ããŒããã©ã³ã«ãæžãè¶³ããã
ãç§ã¯ãã®æ£è ããã蚺å¯ãããªãŠããå°éå»ã§ãã蚺å¯ã§ã¯é¢ç¯ã®è «ããç±æãROMå¶éã¯èªããŸããã§ãããå ã»ã©ã®åçãšããã®èšºå¯ã®æ å ±ã®äž¡æ¹ãèžãŸããŠãäœãåãã£ãŠããŠãäœããŸã åãããªãã®ãããæ£è ããã«åããããã説æããŠãã ããã
AIãå ¥ããäžè é¢è«ããã ããã§ã¢ã§ãªããã°ãããªããAIã䜿ã£ãŠæ£æçã«èªå°ããªãããã«ããã 客芳çãªããšãå ¥ããã
AIã®çãã¯å€ãã£ããæ£è ãããããªãã»ã©ããšã¹ããã©ã«éä»ãã«ãªã£ãã
æèšã§ããããšã¯ãAIãšæŠã£ãŠãããããšã¯ãªãããšããããšã§ããã
Don't fight the patient's AI. Join the conversation.
AIãšæŠãããäŒè©±ã«åå ãããã
次ã«ããã§ããAIã¯ããèšã£ãŠããŸãããšèšãããããæãåºããŠã»ãããå€ãã®æ£è ã¯AIãèŠãŠããããšãå»åž«ã«äŒããŠããªããç®ã®åã®äººã¯ããããå·®ãåºããŠããããšããããšãããã«ã¯æç¢ºãªææãããã
ããããªãã§ãããã§ã¯ãããªãã®æããšãã®AIã®èããåèã«ãããã®ã§ã¡ãã£ãšèŠããŠããããŸããã
ãã¶ããããããã§ããã